These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 21867543)

  • 1. Functional characterization of the complement receptor type 1 and its circulating ligands in patients with schizophrenia.
    Arakelyan A; Zakharyan R; Khoyetsyan A; Poghosyan D; Aroutiounian R; Mrazek F; Petrek M; Boyajyan A
    BMC Clin Pathol; 2011 Aug; 11():10. PubMed ID: 21867543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leucocyte complement receptor 1 (CR1/CD35) transcript and its correlation with the clinical disease activity in rheumatoid arthritis patients.
    Anand D; Kumar U; Kanjilal M; Kaur S; Das N
    Clin Exp Immunol; 2014 Jun; 176(3):327-35. PubMed ID: 24433281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered erythrocyte C3b receptor expression, immune complexes, and complement activation in homosexual men in varying risk groups for acquired immune deficiency syndrome.
    Tausk FA; McCutchan A; Spechko P; Schreiber RD; Gigli I
    J Clin Invest; 1986 Oct; 78(4):977-82. PubMed ID: 2944915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hind III genomic polymorphism of the C3b receptor (CR1) in patients with SLE: low erythrocyte CR1 expression is an acquired phenomenon.
    Kumar A; Kumar A; Sinha S; Khandekar PS; Banerjee K; Srivastava LM
    Immunol Cell Biol; 1995 Oct; 73(5):457-62. PubMed ID: 8595925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The complement fixing ability of putative circulating immune complexes in rheumatoid arthritis and its relationship to extra-articular disease.
    Bourke BE; Moss IK; Mumford P; Horsfall A; Maini RN
    Clin Exp Immunol; 1982 Jun; 48(3):726-32. PubMed ID: 6981475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlations of C1q- and C3d-bearing circulating immune complexes with immunopathological disease activity in lupus nephritis patients.
    Muso E; Yashiro M; Ito Y; Yoshida H; Sasayama S
    Nihon Jinzo Gakkai Shi; 1994 Apr; 36(4):345-54. PubMed ID: 8022107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C1q and C4b bind simultaneously to CR1 and additively support erythrocyte adhesion.
    Tas SW; Klickstein LB; Barbashov SF; Nicholson-Weller A
    J Immunol; 1999 Nov; 163(9):5056-63. PubMed ID: 10528211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement receptor (CR1) and IgG or IgA on erythrocytes and in circulating immune complexes in patients with glomerulonephritis.
    Coppo R; Amore A; Roccatello D; Amoroso A; Maffei S; Quattrocchio G; Molino A; Gianoglio B; Piccoli G
    Nephrol Dial Transplant; 1989; 4(11):932-8. PubMed ID: 2516882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of leukocyte CR1 gene transcription with the disease severity and renal involvement in systemic lupus erythematosus.
    Verma J; Arora V; Marwaha V; Kumar A; Das N
    Lupus; 2005; 14(4):273-9. PubMed ID: 15864913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced complement receptor 1 (CR1, CD35) transcription in systemic lupus erythematosus.
    Arora V; Verma J; Dutta R; Marwah V; Kumar A; Das N
    Mol Immunol; 2004 Jun; 41(4):449-56. PubMed ID: 15163541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C1q acts synergistically with phorbol dibutyrate to activate CR1-mediated phagocytosis by human mononuclear phagocytes.
    Bobak DA; Frank MM; Tenner AJ
    Eur J Immunol; 1988 Dec; 18(12):2001-7. PubMed ID: 2975599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythrocyte complement receptor type 1 (CR1) expression and circulating immune complex (CIC) levels in hydralazine-induced SLE.
    Mitchell JA; Batchelor JR; Chapel H; Spiers CN; Sim E
    Clin Exp Immunol; 1987 May; 68(2):446-56. PubMed ID: 2958187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low expression of erythrocyte complement receptor type 1 in chronic hepatitis C patients.
    Kanto T; Hayashi N; Takehara T; Katayama K; Kato M; Akiyama M; Kasahara A; Fusamoto H; Kamada T
    J Med Virol; 1996 Oct; 50(2):126-34. PubMed ID: 8915878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Circulating immune complexes and complement breakdown products in childhood IgA nephropathy].
    Tanaka C; Suhara Y; Kikkawa Y
    Nihon Jinzo Gakkai Shi; 1991 Aug; 33(8):709-17. PubMed ID: 1770631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship of serum alpha-fetoprotein to circulating immune complexes and complements in patients with hepatitis B surface antigen-positive hepatocellular carcinoma.
    Tsai JF; Tsai JH; Chang WY
    Gastroenterol Jpn; 1990 Jun; 25(3):388-93. PubMed ID: 1694150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Elevated levels of circulating immune complexes -C3d and-C1q as a criterion for acute extraintestinal manifestations of ulcerative colitis].
    Sagynbaeva VÉ; Lazebnik LB
    Eksp Klin Gastroenterol; 2014; (7):18-24. PubMed ID: 25842401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of complement receptors type 1 (CR1, CD35) and 2 (CR2, CD21) in promoting C3 fragment deposition and membrane attack complex formation on normal peripheral human B cells.
    Nielsen CH; Pedersen ML; Marquart HV; Prodinger WM; Leslie RG
    Eur J Immunol; 2002 May; 32(5):1359-67. PubMed ID: 11981823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement C3b receptors on erythrocytes in patients with juvenile rheumatoid arthritis.
    Thomsen BS; Heilmann C; Jacobsen SE; Pedersen FK; Morling N; Jakobsen BK; Svejgaard A; Nielsen H
    Arthritis Rheum; 1987 Sep; 30(9):967-71. PubMed ID: 2959290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of disease activity with circulating immune complexes (C1qbA) and complement breakdown products (C3D) in patients with systemic lupus erythematosus. A prospective study.
    Swaak AJ; Groenwold J; Hannema A; Hack CE
    Rheumatol Int; 1985; 5(5):215-20. PubMed ID: 3877968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levels of complement receptor type one (CR1, CD35) on erythrocytes, circulating immune complexes and complement C3 split products C3d and C3c are not changed by short-term physical exercise or training.
    Thomsen BS; Rødgaard A; Tvede N; Hansen FR; Steensberg J; Halkjaer Kristensen J; Pedersen BK
    Int J Sports Med; 1992 Feb; 13(2):172-5. PubMed ID: 1555909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.